Research/Quality/Performance Improvement
Prostate cancer (PCa) patients treated with injectable androgen deprivation therapy (ADT) are particularly vulnerable during a pandemic because they may not be able to self-administer treatment and may be required to visit a clinic/hospital for injections.
Richard N. Boyajian, Ashleigh M. Kowtoniuk, PA, APRN-NP, Krystle R. Boyajian, Mark J. Mackin, MBA, RT(T)
Prostate cancer is the most common male malignancy. In 2021, the United States will see an estimated 248,530 new cases, 34,130 deaths, and more than 3 million survivors.
The oncology nurse navigator (ONN) plays a central role in decreasing distress and increasing satisfaction in patients with breast cancer.
Adam C. Powell, PhD, Christopher T. Lugo, BBA, Jeremy T. Pickerell, MAT, James W. Long, BSBA, Bryan A. Loy, MD, MBA, Amin J. Mirhadi, MD
When a patient with prostate cancer needs radiation therapy (RT), their physician submits an order for RT to a prior authorization program, which assesses its concordance with clinical guidelines and evidence-based practices.
Lung cancer is the leading cause of death in the United States, with approximately 235,760 new cases and 131,880 deaths expected to occur in 2021.
Lung Cancer Diagnosis Shift to Early Stage via Comprehensive and Multidisciplinary Thoracic Programs
Lung cancer has the highest mortality of all tumor sites, with more deaths than breast, colon, and prostate cancers combined.
Kambiz Dardashti, MD, FACS, Alec S. Koo, MD, FACS, Shirley H. Lee, CRNP-FNP, MPH, Ross Camua, Jessica Mitchell, Shelby Houston
Like most urology practices, Skyline Urology in California had the challenge of juggling scheduled patients with several unscheduled patients with acute urinary tract infection (UTI) symptoms.
Genesis Healthcare Partners (GHP), in San Diego, CA, has been proactively seeking effective solutions to improve prostate cancer (PCa) advancement detection rates.
Nurse navigators play a vital role in promoting quality oncology care to all patients.
Ashley Giacobbi, MSN, RN, ACNS-BC, AOCNS, Melissa Komlosi Melendez, MSN, RN, CPNP-PC, Leah Szumita, MS, RN, CCRN, ACNS-BC, Kerry Lee, BS
Enrollment rates for cancer clinical trials, estimated to be as low as 8% nationally with significant variability based on patient demographics, have been an ongoing barrier to scientific advances in oncology care.
